Shanghai Bio-heart Biological Technology Co., Ltd.’s (HKG:2185) stock price dropped 12% last week; individual investors would not be happy

Key Insights

We’ve found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

A look at the shareholders of Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185) can tell us which group is most powerful. With 38% stake, individual investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, individual investors as a group endured the highest losses last week after market cap fell by HK$257m.

Let’s take a closer look to see what the different types of shareholders can tell us about Shanghai Bio-heart Biological Technology.

Check out our latest analysis for Shanghai Bio-heart Biological Technology

What Does The Institutional Ownership Tell Us About Shanghai Bio-heart Biological Technology?

Institutions…